AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / LABORATORY ANALYTICAL INSTRUMENTS
Alamar Biosciences, Inc. Common Stock
XNAS · usd
SIC 3826 · LABORATORY ANALYTICAL INSTRUMENTS
FIGI BBG012FD22X6
30.69▲ 0.97 (3.26%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
—
Trailing P/E
—
Price / Sales
—
EV / Revenue
—
EV / EBITDA
—
Financial Highlights
Revenue (TTM)
—
Net Income (TTM)
—
EBITDA
—
Diluted EPS (TTM)
—
EBITDA Margin
—
Net Debt
—
Trading Information
Previous Close
29.72
Day's Range
28.61 – 31.46
52-Week Range
18.85 – 39.61
Volume
715.8K
Avg Volume
728.1K
Share Statistics
Shares Outstanding
Employees
—
Exchange
XNAS
Listed
2026-04-17
Share count as of July 31, 2026

Alamar Biosciences, Inc. Common Stock (ALMR) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Alamar Biosciences, Inc. Common Stock (ALMR)
What is Alamar Biosciences, Inc. Common Stock's Market Cap?
Alamar Biosciences, Inc. Common Stock's Market Cap is $2.1B, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · ALMRAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Jun 30, 2025Mar 31, 2025
Revenue:
Total revenue
Cost of revenue:
Total cost of revenue
Gross profit
% of revenue60.2%55.5%
Operating expenses:
Research and development
Selling, general and administrative
Total operating expenses
% of revenue106.2%103.0%
Loss from operations
% of revenue-46.0%-47.4%
Interest income, net
Interest expense
Loss on remeasurement of convertible notes
Other (expense) income, net
Net loss before income tax
Net loss
% of revenue-44.9%-81.9%
Net loss per share, basic
Net loss per share, diluted